Literature DB >> 16933094

Predictions of onset of crystallization from experimental relaxation times I-correlation of molecular mobility from temperatures above the glass transition to temperatures below the glass transition.

Chandan Bhugra1, Rama Shmeis, Steven L Krill, Michael J Pikal.   

Abstract

PURPOSE: Predicting onsets of crystallization at temperatures below T (g), from data above T (g), would require that the correlation between crystallization onset and mobility is same above and below T (g), and the techniques being used to measure mobility above and below T (g) are measuring essentially the same kind of mobility. The aim of this work is to determine if the relaxation times obtained using different techniques (DSC, TAM) below T (g) correlate with relaxation time obtained above T (g) using dielectric spectroscopy.
METHODS: Model compounds for this work were chosen based on their varied DeltaH (f), DeltaC (p)(T (g)) and H-bonding in crystalline state vs. amorphous state. Relaxation times above T (g) were determined by the simultaneous fit of real and imaginary permittivity to the Cole-Davidson model. Tau and beta below T (g) were determined using isothermal microcalorimetry (TAM) or MDSC. MDSC was used to calculate Kauzmann temperature and strength of the glass using established relationships.
RESULTS: Indomethacin, nifedipine and flopropione showed Arrhenius temperature dependence throughout the entire temperature range and extrapolation of tau ( beta ) measured above T (g) by dielectric relaxation agreed with tau ( beta ) measured below T (g) by TAM/MDSC. Ketoconazole, however, showed the expected VTF behavior. For at least two compounds compared (indomethacin and ketoconazole), relaxation times measured by TAM and MDSC did not agree, with TAM giving significantly lower values of tau ( beta ), but TAM and MDSC relaxation times appeared to extrapolate to a common value at T (g).
CONCLUSIONS: It was found that, for all cases studied, relaxation time constants determined above and below T (g) did appear to extrapolate to the same value around T (g) indicating that molecular mobility measured above and below T (g) using different techniques is highly correlated.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16933094     DOI: 10.1007/s11095-006-9079-1

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  18 in total

1.  An investigation into the thermal behaviour of an amorphous drug using low frequency dielectric spectroscopy and modulated temperature differential scanning calorimetry.

Authors:  R He; D Q Craig
Journal:  J Pharm Pharmacol       Date:  2001-01       Impact factor: 3.765

2.  Dynamics of pharmaceutical amorphous solids: the study of enthalpy relaxation by isothermal microcalorimetry.

Authors:  Jinsong Liu; Daniel R Rigsbee; Carol Stotz; Michael J Pikal
Journal:  J Pharm Sci       Date:  2002-08       Impact factor: 3.534

3.  The molecular mobility of supercooled amorphous indomethacin as a function of temperature and relative humidity.

Authors:  V Andronis; G Zografi
Journal:  Pharm Res       Date:  1998-06       Impact factor: 4.200

4.  Some physicochemical properties of glassy indomethacin.

Authors:  E Fukuoka; M Makita; S Yamamura
Journal:  Chem Pharm Bull (Tokyo)       Date:  1986-10       Impact factor: 1.645

5.  A spectroscopic investigation of hydrogen bond patterns in crystalline and amorphous phases in dihydropyridine calcium channel blockers.

Authors:  Xiaolin Charlie Tang; Michael J Pikal; Lynne S Taylor
Journal:  Pharm Res       Date:  2002-04       Impact factor: 4.200

6.  The solid-state stability of amorphous quinapril in the presence of beta-cyclodextrins.

Authors:  Jinjiang Li; Yushen Guo; George Zografi
Journal:  J Pharm Sci       Date:  2002-01       Impact factor: 3.534

7.  Molecular mobility and fragility in indomethacin: a thermally stimulated depolarization current study.

Authors:  N T Correia; J J Ramos; M Descamps; G Collins
Journal:  Pharm Res       Date:  2001-12       Impact factor: 4.200

8.  Physical stability and solubility advantage from amorphous celecoxib: the role of thermodynamic quantities and molecular mobility.

Authors:  Piyush Gupta; Garima Chawla; Arvind K Bansal
Journal:  Mol Pharm       Date:  2004 Nov-Dec       Impact factor: 4.939

9.  Molecular mobility-based estimation of the crystallization rates of amorphous nifedipine and phenobarbital in poly(vinylpyrrolidone) solid dispersions.

Authors:  Yukio Aso; Sumie Yoshioka; Shigeo Kojima
Journal:  J Pharm Sci       Date:  2004-02       Impact factor: 3.534

10.  Molecular mobility of amorphous pharmaceutical solids below their glass transition temperatures.

Authors:  B C Hancock; S L Shamblin; G Zografi
Journal:  Pharm Res       Date:  1995-06       Impact factor: 4.200

View more
  3 in total

1.  A practical method to predict physical stability of amorphous solid dispersions.

Authors:  Stéphanie Greco; Jean-René Authelin; Caroline Leveder; Audrey Segalini
Journal:  Pharm Res       Date:  2012-03-16       Impact factor: 4.200

2.  Fast surface crystallization of amorphous griseofulvin below T g.

Authors:  Lei Zhu; Janan Jona; Karthik Nagapudi; Tian Wu
Journal:  Pharm Res       Date:  2010-04-23       Impact factor: 4.200

3.  Molecular motions in sucrose-PVP and sucrose-sorbitol dispersions: I. Implications of global and local mobility on stability.

Authors:  Sisir Bhattacharya; Raj Suryanarayanan
Journal:  Pharm Res       Date:  2011-04-18       Impact factor: 4.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.